INSIDER · CIK 1464583
Megna Michael R
CHIEF ACCOUNTING OFFICER at Kiniksa Pharmaceuticals International, plc (KNSA)
↗4 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$369KSold on the market
1Companies
Sep 3, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 202616:40 | Sep 3, 2026 | KNSAKiniksa Pharmaceuticals International, plc | CHIEF ACCOUNTING OFFICER | S · Sell10b5-1 | $80.30 | −4,600 | 29,062 | -14% | −$369K | ||
| Sep 3, 202616:40 | Sep 1, 2026 | KNSAKiniksa Pharmaceuticals International, plc | CHIEF ACCOUNTING OFFICER | M · Exercise10b5-1 | — | +11,496 | 39,193 | +42% | — | ||
| Sep 3, 202616:40 | Sep 1, 2026 | KNSAKiniksa Pharmaceuticals International, plc | CHIEF ACCOUNTING OFFICER | F · Tax10b5-1 | $79.28 | −5,531 | 33,662 | -14% | $438K | ||
| Sep 3, 202616:40 | Jul 15, 2026 | KNSAKiniksa Pharmaceuticals International, plc | CHIEF ACCOUNTING OFFICER | A · Grant10b5-1Late 50d | $33.50 | +279 | 27,697 | +1% | $9K |